NantHealth, a subsidiary of NantWorks, LLC, a high speed secure cloud-based information technology provider combining genomic science and big data to transform healthcare, has completed the acquisition of Harris Corporation's (NYSE:HRS) commercial Healthcare Solutions (HCS) business, a clinical systems integration innovator. Harris retained its U.S. government healthcare services business. Financial terms of the transaction were not disclosed.
Harris Healthcare Solutions disruptive technology platform includes a state-of-the-art health services operating system (FusionOS™), innovative business intelligence tools (FusionIQ™) and a comprehensive suite of advanced care collaboration software (FusionFX®) that provides an integrated, vendor neutral system for health information exchange and care collaboration. Harris Healthcare Solutions’ worldwide client base includes dozens of leading healthcare organisations including leading health systems across the NHS.
This news is announced at the same time as recent investment in the UK is completed to deliver state-of-the-art UK based supercomputing and cloud infrastructure that includes N3 and private dark fibre networking and connectivity - a capability which complements infrastructure support to Harris' European customers by BT.
These developments demonstrate NantHealth's continuing commitment to the NHS to support the transformation of care delivery using the most advanced molecular genomic and proteomic diagnostics capabilities and enable access to NantHealth's automated NantOmics Analytics Platform (NantContraster™) for genomics sequencing interpretation and annotation and unique IT integration capabilities, for better informed precision treatment selection and care coordination.
"The acquisition of Harris Healthcare Solutions brings unique and proven technology that significantly furthers our stated goal to improve patient outcomes by efficiently providing healthcare professionals with integrated, clinically relevant patient-centric information in real-time," said Dr. Patrick Soon-Shiong, CEO and founder of NantHealth. "At the same time, we have added an extensive client base of leading clinical and health IT innovators across North America and Europe, as well as a talented and experienced leadership team."
"We are excited about the opportunity we have to support leading NHS organisations and health economies accelerate the delivery of new models of integrated, pro-active and personalised care. The acquisition of Harris Healthcare Solutions provides a tremendous platform on which to support our own growth and the continued drive for more efficient, effective and safe care for patients across the UK," said Bob Watson, President of NantHealth.
"We are excited to join forces with NantHealth," said Vishal Agrawal, MD, former President, Harris Healthcare Solutions and now, Senior Vice President at NantHealth. "The integrated product offering creates a healthcare informatics powerhouse with the scale, capabilities and depth to deliver even greater value to our clients."
The company has approximately 170 employees, including a seasoned management team and a world-class engineering base of which many are based in the UK, and who will further strengthen NantHealth UK's flourishing operations.
About NantHealth
NantHealth, a member of the NantWorks ecosystem of companies, is a healthcare transformational cloud-based IT company converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care, in the time of need, anywhere, anytime. NantHealth works to transform clinical delivery with actionable clinical intelligence at the moment of decision, enabling clinical discovery through real-time machine learning systems. The company's technology empowers clinicians, patients and researchers to transcend the traditional barriers of today's healthcare system. By converging molecular science, near real-time patient signal monitoring, computer science and big data technology, the NantHealth Clinical Operating System (cOS) platform empowers providers, patients, and commissioners to coordinate best care, monitor outcomes and control cost in real-time. This is the first system of its kind in healthcare, enabling 21st century coordinated care at a lower cost, enabling value-based population health management at a single patient level and at the population at large.
About NantOmics
NantOmics, a member of the NantWorks ecosystem of companies, delivers medical diagnostics capabilities with the intent of providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care. NantOmics is the first molecular diagnostics company to pioneer an integrated approach to unearthing the genomic and proteomic variances that initiate and drive cancer, by analysing both normal and tumour cells from the same patient and following identified variances through from DNA to RNA to protein to drug. NantOmics has a highly scalable cloud-based infrastructure capable of storing and processing thousands of genomes a day, computing genomic variances in near real-time, and correlating proteomic pathway analysis with quantitative multi-plexed protein expression analysis from the same micro-dissected tumour sample used for genomic analysis.
About NantContrastor
Accurately assessing the state of a patient's genome is one of the most powerful tools in the emerging field of personalised medicine. NantOmics applies its leading, novel genomic analyses to rapidly discover variants in a patient's raw genomics data using the latest sequencing technologies combined with advanced statistics and machine learning techniques.
NantContraster annotates all variants against a knowledge database comprising all known and probable disease-associated genes to rank the genomic alterations that have the highest clinical relevance. When applied to cancer tumour/normal samples, our analysis is capable of quickly identifying genomic alterations that could lead to tumorigenesis for a fraction of the cost of conventional approaches. NantContraster is capable of concurrently processing many samples to handle large workflows from researchers and hospital settings.